Community Health Workers and mHealth for Sickle Cell Disease Care

NCT03648710 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 405

Last updated 2024-12-04

No results posted yet for this study

Summary

This study will compare the effectiveness of two self-management support interventions-Community Health Workers (CHW) and mobile health (mHealth)-versus enhanced usual care to improve health-related quality of life and acute care use for transitioning youth with sickle cell disease (SCD), and identify and quantify mediators and moderators of intervention treatment effects.

Conditions

Interventions

OTHER

Peer Community Health Worker

Participants will be communicating with their CHWs on a weekly basis, which is consistent with other successful community health worker protocols with published efficacy. Community Health Workers will be peers with sickle cell disease, who have successfully transitioned and are under 30 years of age.

OTHER

Mobile Health

A mobile health application created as a resource for young adults transitioning.

Sponsors & Collaborators

  • St. Christopher's Hospital for Children

    collaborator OTHER
  • Children's Hospital Medical Center, Cincinnati

    collaborator OTHER
  • Steven and Alexandra Cohen Children's Medical Center

    collaborator INDIV
  • Connecticut Children's Medical Center

    collaborator OTHER
  • Patient-Centered Outcomes Research Institute

    collaborator OTHER
  • Children's Hospital of Philadelphia

    lead OTHER

Principal Investigators

  • David Rubin, MD · Children's Hospital of Philadelphia

  • Sophia Jan, MD · Cohen's Children Medical Center/Northwell Health

  • Kim Smith-Whitley, MD · Children's Hospital of Philadelphia

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
17 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-01-15
Primary Completion
2024-08-31
Completion
2024-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03648710 on ClinicalTrials.gov